Skip to main content

Acute Coronary Syndrome Following Long-Term Erlotinib Treatment Cover

.blurhash-client-img { display: none !important; }

Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Internal Medicine

Volume 15 (2018): Issue 3 (July 2018)

By: Traian Constantin Panciu, Bianca Masgras, Catrinel Ciuca, Raluca Ciomag, Anca Mihăilescu and Adriana Gurghean

Open Access

|Jul 2018

Authors

Traian Constantin Panciu

Clinical Hospital Colţea Bucharest

Bianca Masgras

Clinical Hospital Colţea Bucharest

Catrinel Ciuca

Clinical Hospital Colţea Bucharest

Raluca Ciomag

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila Bucharest, Romania

Anca Mihăilescu

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila Bucharest, Romania

Adriana Gurghean

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila Bucharest, Romania

Articles in this issue

DOI: https://doi.org/10.2478/inmed-2018-0023 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818

Journal RSS Feed

Language: English

Page range: 61 - 66

Published on: Jul 20, 2018

Published by: Romanian Society of Internal Medicine

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

tyrosine kinase inhibitor,

non-small cell lung cancer,

acute coronary syndrome

Related subjects:

Clinical medicine,

Internal medicine,

Internal medicine, other,

Gastroenterology,

© 2018 Traian Constantin Panciu, Bianca Masgras, Catrinel Ciuca, Raluca Ciomag, Anca Mihăilescu, Adriana Gurghean, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 15 (2018): Issue 3 (July 2018)

Previous article